Search results
Found 7339 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments
16 November 2022
Scientists from Oxford University and the University of Birmingham have made the first bone marrow ‘organoids’ that include all the key components of human marrow. This technology allows for the screening of multiple anti-cancer drugs at the same time, as well as testing personalised treatments for individual cancer patients.
Key cause of type 2 diabetes uncovered
14 November 2022
Oxford research reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes.
New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models
10 November 2022
Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.
New tool could help GPs predict and prevent serious falls
8 November 2022
Researchers, led by the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new tool for doctors to identify patients at high risk of serious falls. The tool could have a big impact on the way older patients are managed in primary care, improving targeting of drug treatment and fall prevention strategies for high-risk individuals.
Profiling the entire cancer genome identifies new subgroups of blood cancer
7 November 2022
The University of Oxford has led the largest and most comprehensive analysis of the entire genomic landscape of the commonest type of blood cancer called chronic lymphocytic leukaemia (CLL) as part of the UK’s 100,000 Genomes Project. This work defines five genomic subgroups of CLL and associates these with clinical outcomes, and these subgroups provide a better estimation of patient prognosis than achieved by previous single gene analyses, allowing more tailored patient care.
University of Oxford study provides important insights into TB correlates of protection
7 November 2022
Researchers from the University of Oxford have today reported findings from a study that investigated whether previously identified correlates of protection associated with risk of full-blown tuberculosis (TB) disease could also be associated with risk of infection from the bacteria that causes TB - highlighting certain correlates in the process.
Therapeutic HIV vaccine with Oxford technology achieves encouraging results
4 November 2022
A phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.
Bacterial armour plating has implications for antibiotics
3 November 2022
A new study published in the journal Science Advances sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armour, which has far-reaching implications for the development of antibiotics.
Pancreatic cancer could be diagnosed up to three years earlier
2 November 2022
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research suggests. Weight loss and increasing blood glucose levels are early indicators of pancreatic cancer and could lead to a more timely diagnosis, helping to improve survival rates.
Obituary: Professor Sir Peter J. Morris FRS (17 April 1934 – 29 October 2022)
1 November 2022
It is with great sadness that we report Peter Morris’s death. Peter died peacefully of metastatic colon cancer on Saturday 29 October at the age of 88, at home in Witney, surrounded by his wife Jocelyn and members of his large family. Peter has been one of the greatest Oxford medicine figures and was the third Nuffield Professor of Surgery between 1974 and 2001.
Past two years of MSD Teaching Excellence Awards celebrated
28 October 2022
The 2021 and 2022 MSD Teaching Excellence Awards were celebrated in a ceremony at St Catherine’s College earlier this week.
Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination
28 October 2022
Researchers from Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
Oxford retains top spot for medicine for twelfth consecutive year
27 October 2022
Oxford University has been ranked as the world's best institution for clinical and health teaching and research for the twelfth consecutive year in the latest Times Higher Education World University Rankings.
Oxford contributes to new UK research consortium to tackle monkeypox
26 October 2022
The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium – in which the University of Oxford is a key partner – working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.
New requirements for clinical trials sponsored by the University
24 October 2022
Staff Census: We need you!
24 October 2022
All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!